Table 1.

Patient demographics and risk factors.

	Catheter directed thrombolysis N=53	Anticoagulation Monotherapy N=19	p value
Age	55 ± 15	61 ± 14	.08
Male	32 (60)	11 (58)	.17
White race	45 (85)	18 (95)	.56
Body mass index, kg/m2
Coronary artery disease	9 (17)	6 (32)	.19
Congestive heart failure	1 (2)	1 (5)	.45
Hypertension	24 (45)	11 (58)	.38
Pulmonary disease	4 (8)	3 (16)	.31
Known hypercoagulable disease	2 (4)	1 (5)	.81
Current smoking	11 (21)	1 (5)	.11
Recent travel*	4 (8)	1 (5)	.72
Recent trauma*	2 (4)	0 (0)	.39
Recent surgery*	13 (25)	4 (21)	.64
Current malignancy	2 (4)	0 (0)	.39
Current oral contraceptive use	4 (8)	1 (5)	.72
Glomerular filtration rate	78.3±27.4	77.4±23.1	.55
Troponin, ug/L†	0.7 ± 1.6	0.6 ± 0.7	.83
Brain natriuretic peptide, ng/L†	340.9 ± 315.6	257.9 ± 246.9	.32
D-dimer, †	15.0 ± 13.4	26.6 ± 7.9	.15
Concomitant DVT	34 (64)	13 (68)	.40
Baseline RV/LV ratio on CT	1.8 ± 0.4	1.7 ± 0.3	.32

Values are mean±SD or n (%);

^*Within 30 days of admission;

^†Highest value within 24 hours of admission; CT = computed tomography; DVT = deep vein thrombosis; LV = left ventricular; RV = right ventricular. Categorical variables were compared using the Fisher exact test and continuous variables were compared using the Wilcoxon rank-sum test